Cargando…

Correction: Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/ Akt signaling pathway in gastric cancer

Detalles Bibliográficos
Autores principales:	Xu, Jiahui, Liu, Deying, Niu, Huilin, Zhu, Guifang, Xu, Yangwei, Ye, Danli, Li, Jian, Zhang, Qingling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843975/ https://www.ncbi.nlm.nih.gov/pubmed/36647144 http://dx.doi.org/10.1186/s13046-023-02593-5

Ejemplares similares

Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
por: Xu, Jiahui, et al.
Publicado: (2017)

WTX inhibits gastric cancer migration through the reversal of epithelial-mesenchymal transition
por: Ye, Danli, et al.
Publicado: (2018)

Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway
por: Li, Jian, et al.
Publicado: (2020)

Correction to: Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway
por: Li, Jian, et al.
Publicado: (2021)

Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation
por: Poudel, Sunil, et al.
Publicado: (2022)

Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway
por: Wang, Sheng-Chun, et al.
Publicado: (2015)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

A new dimension in drug discovery: reversing epithelial–mesenchymal transition (EMT)
por: Yun-Ju Huang, Ruby, et al.
Publicado: (2016)

Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer
por: Wang, Ye, et al.
Publicado: (2020)

Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
por: Guo, Kaibo, et al.
Publicado: (2021)

The DeltaN p63 Promotes EMT and Metastasis in Bladder Cancer by the PTEN/AKT Signalling Pathway
por: Tian, Yong-Hua, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition (EMT) 2021
por: Manfioletti, Guidalberto, et al.
Publicado: (2022)

Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN
por: Han, Mingli, et al.
Publicado: (2012)

Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer [Retraction]
Publicado: (2023)

Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway
por: Li, Ling-Li, et al.
Publicado: (2020)

The Role of PTEN in Epithelial–Mesenchymal Transition
por: Fedorova, Olga, et al.
Publicado: (2022)

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
por: Yoshida, T, et al.
Publicado: (2014)

Doxorubicin-Induced Cancer Cell Senescence Shows a Time Delay Effect and Is Inhibited by Epithelial-Mesenchymal Transition (EMT)
por: Hu, Xuerui, et al.
Publicado: (2019)

SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration
por: Eguchi, Takanori, et al.
Publicado: (2022)

JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling
por: Lei, Xiong, et al.
Publicado: (2016)

Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling
por: Dai, Hanhan, et al.
Publicado: (2020)

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells
por: HUANG, FANG, et al.
Publicado: (2014)

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial- mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway
por: Yuan, Li, et al.
Publicado: (2019)

Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial-mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway
por: Yuan, Li, et al.
Publicado: (2022)

MicroRNA-10 Family Promotes the Epithelial-to-Mesenchymal Transition in Renal Fibrosis by the PTEN/Akt Pathway
por: Wang, Chaokun, et al.
Publicado: (2022)

Resveratrol protects the integrity of alveolar epithelial barrier via SIRT1/PTEN/p‐Akt pathway in methamphetamine‐induced chronic lung injury
por: Wang, Xin, et al.
Publicado: (2020)

Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway
por: Li, Jie, et al.
Publicado: (2018)

Role of Metabolic Reprogramming in Epithelial–Mesenchymal Transition (EMT)
por: Kang, Hyunkoo, et al.
Publicado: (2019)

The Epithelial-to-Mesenchymal Transition (EMT), a Particular Case
por: Cebrià-Costa, Joan Pau, et al.
Publicado: (2014)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases
por: Sarrand, Julie, et al.
Publicado: (2023)

A novel anti-cancer effect of resveratrol: reversal of epithelial-mesenchymal transition in prostate cancer cells
por: LI, JIANPING, et al.
Publicado: (2014)

WFDC2 contributes to epithelial–mesenchymal transition (EMT) by activating AKT signaling pathway and regulating MMP-2 expression
por: Chen, Yao, et al.
Publicado: (2019)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signaling pathway in breast cancer
por: Jin, Xiaoxia, et al.
Publicado: (2019)

JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells
por: Tang, Bo, et al.
Publicado: (2015)

MicroRNA-216a promotes the metastasis and epithelial–mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway
por: Liu, Haizhi, et al.
Publicado: (2017)

Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol
por: Buhrmann, Constanze, et al.
Publicado: (2019)

Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases
por: Zvaifler, Nathan J
Publicado: (2006)

Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
por: Grant, Campbell M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1h0krkcfphgp3evfar4bo1v4qf